非转移性结肠癌患者前哨淋巴结与骨髓肿瘤细胞播散的比较分析:一项前瞻性多中心研究
该前瞻性多中心研究纳入122例I-III期结肠癌患者,术中行前哨淋巴结活检和骨髓穿刺,检测小淋巴结肿瘤浸润(SNTI)和骨髓微转移(BMM)。结果显示SNTI与BMM的发生无关联,但两者均为无病生存期(DFS)和总生存期(OS)的独立不良预后因素,且同时存在时预后最差。
要点
- SNTI与BMM在I-III期结肠癌中无显著关联。
- SNTI和BMM均为DFS和OS的独立负性预后因素。
- 两者同时存在时DFS和OS显著更差,预后最差。
核心结论
- SNTI与BMM的发生无关联,但两者均为独立负性预后因素,同时存在时预后显著更差。
研究设计与样本
- 前瞻性多中心研究,纳入122例I-III期结肠癌患者,行骨髓穿刺和前哨淋巴结 mapping,随访超过6年,无失访。
主要发现
- SNTI见于21例(17.2%),BMM见于46例(37.7%)。
临床怎么用
- SNTI和BMM检测可提供独立于分期的预后信息,两者同时阳性提示预后极差,或可指导辅助治疗强度。
局限性
- 样本量较小(122例),仅纳入I-III期结肠癌,随访超过6年,统计效力有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Small nodal tumor infiltrates (SNTI; isolated tumor cells and micrometastases) in sentinel lymph nodes and bone marrow micrometastases (BMM) were independently described as prognostic factors in patients with colon cancer. OBJECTIVE: To examine the association between the occurrence of SNTI and BMM as well as their prognostic relevance. DESIGN, SETTING, AND PARTICIPANTS: This prospective study was conducted at 3 university-affiliated institutions in Switzerland between May 2000 and December 2006. Statistical analyses were performed in October 2016. A total of 122 patients with stage I to III colon cancer were included. Follow-up time exceeded 6 years, with no patients lost to follow-up. INTERVENTIONS: Bone marrow aspiration from the iliac crests and in vivo sentinel lymph node mapping were performed during open standard oncological resection. Bone marrow aspirates were stained with the pancytokeratin marker A45-B/B3. All sentinel lymph nodes underwent multilevel sectioning and were stained with hematoxylin-eosin and the pancytokeratin marker AE1/AE3. MAIN OUTCOMES AND MEASURES: Association of SNTI in sentinel lymph nodes and BMM in patients with stage I to III colon cancer and the prognostic effect on disease-free survival (DFS) and overall survival (OS). RESULTS: Of the 122 patients, 63 (51.6%) were female, with a mean (SD) age of 71.2 (11.7) years. Small nodal tumor infiltrates and BMM were found in a total of 21 patients (17.2%) and 46 patients (37.7%), respectively. The occurrence of BMM was not associated with the presence of SNTI by standard correlation (κ, -0.07; 95% CI, -0.29 to 0.14; P = .49) nor by univariate logistic regression analysis (odds ratio, 0.64; 95% CI, 0.22-1.67; P = .37) or multivariate logistic regression analysis (odds ratio, 1.09; 95% CI, 0.34-3.28; P = .88). The presence of SNTI was an independent negative prognostic factor for DFS (hazard ratio [HR], 2.93; 95% CI, 1.24-6.93; P = .02) and OS (HR, 4.04; 95% CI, 1.56-10.45; P = .005), as was BMM (HR, 2.07; 95% CI, 1.06-4.06; P = .04; and HR, 2.68; 95% CI, 1.26-5.70; P = .01; respectively). The combined detection of BMM and SNTI demonstrated the poorest DFS (HR, 6.73; 95% CI, 2.29-19.76; P = .006) and OS (HR, 5.96; 95% CI, 1.66-21.49; P = .03). CONCLUSIONS AND RELEVANCE: This study demonstrates no association between the occurrence of SNTI and BMM in patients with stage I to III colon cancer. However, both SNTI and BMM are independent negative prognostic factors regarding DFS and OS, and the occurrence of both is associated with significantly worse prognosis compared with either one of them. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00826579.
引用
- Weixler B, Viehl CT, Warschkow R, et al. Comparative Analysis of Tumor Cell Dissemination to the Sentinel Lymph Nodes and to the Bone Marrow in Patients With Nonmetastasized Colon Cancer: A Prospective Multicenter Study. JAMA Surg. 2017. PMID: 28593306. doi:10.1001/jamasurg.2017.1514
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。